Possible scenario
Turnaround Gains Traction
30% Chance
Management's plan starts to look credible as manufacturing expansion, cost discipline and renewed prescription momentum stabilize expectations. The stock recovers part of its lost premium, though investors remain more cautious than during the 2023-2024 growth boom.
Secondary impacts
- Healthcare +0.1%
Tickers
- LLY-1.2%
- VKTX-1.0%
Portfolio impact
S&P 500-0.0%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.